The rise of Viagra and its impact on the pharmaceutical landscape presents a intricate question for traders. While the first sales data were astounding, the intellectual property has ended, leading to a flood of generic alternatives that are reducing revenue. In addition, the sector is facing difficulties related to population trends and changing h